Top 5 Value Stocks To Watch Right Now

Outside of China, Mexico is the ‘most hated’ country in Trump’s America. Last year, a survey of investors conducted by Barclays forecast the Mexican peso going to 26. It’s now at 21. If it goes to 26, buy Cancun, people. Despite all the media noise about Trump versus the Mexicans, the question investors are asking now is when will Mexico be cheap enough not to ignore? So far, it’s kind of expensive.

Mexico’s President Enrique Pena Nieto — in the cross hairs of a new American president. So far, the currency has proven to be surprisingly resilient. (AP Photo/Rebecca Blackwell)

Mexico foreign debt is investment grade. The peso has not yet undermined Mexico’s ability to service its foreign debt even as the currency has lost precisely 93.92% of its value against the dollar since January 12, 2007. It’s been 10 years of a straight trip down.  Over the last 12 months, the peso has weakened more than the Ukrainian hryvnia, and Ukraine is currently battling the Russians and lost a chunk of real estate to Moscow in March 2014.

Top 5 Value Stocks To Watch Right Now: USG Corporation(USG)

Advisors’ Opinion:

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

Top 5 Value Stocks To Watch Right Now: Calumet Specialty Products Partners L.P.(CLMT)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Two turnaround stocks drawing attention from investors are propane distributor Ferrellgas Partners L.P. (NYSE:FGP) and specialty refiner Calumet Specialty Products Partners LP (NASDAQ:CLMT). They’ve had very different trajectories in the last year, with the former losing 35% and the latter gaining 108%. However, the biggest problem facing each business is the same: suffocating debt.

  • [By Reuben Gregg Brewer]

    Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) is attempting to shift gears as it refocuses around higher-margin refined chemicals products. The plan sounds good on paper, and the independent refiner appears to be making progress. However, after a doubling of the price over the past year, most investors need to think carefully before jumping on this bandwagon. Here’s why.

Top 5 Value Stocks To Watch Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Daniel Miller]

    As major indices continue to trade near record highs it has become more difficult to hunt down valuable stocks at cheap prices. But if you can find those stocks, and if those stocks happen to boast a dividend yield of 3%, it gives investors an opportunity for solid returns at a time when many stocks are overpriced. Both Williams-Sonoma, Inc. (NYSE:WSM) and Ford Motor Company (NYSE:F) offer investors just that opportunity. Here’s why.

Top 5 Value Stocks To Watch Right Now: ServisFirst Bancshares, Inc.(SFBS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    ServisFirst Bancshares (NASDAQ:SFBS) Q1 2018 Earnings Conference CallApril 16, 2018 4:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Value Stocks To Watch Right Now: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Leave a Reply

Your email address will not be published. Required fields are marked *